Home › Companies › INSMED INC. › 2024-2025

INSMED INC. 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and INSMED INC.’s Form 8-K, filed 2025-05-16 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 7Reported items
  • 429Asset managers
  • 3,119Fund votes
  • 2025-05-15Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore INSMED INC. in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by INSMED INC.

These tallies are INSMED INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-16 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

INSMED INC. — official shareholder meeting results, meeting held 2025-05-15
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Leo Lee 128,784,508---- 18,556,20118,995,441 Majority: yes
Elect Director: William H. Lewis 140,744,212---- 6,596,49718,995,441 Majority: yes
By the following vote, shareholders approved, on an advisory, non-binding basis, the compensation of our named executive officers, as disclosed in the Proxy Statement: 142,263,7774,990,96985,963 --18,995,441 Majority: yes
By the following vote, shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025: 160,950,4405,335,83649,874 ---- Majority: yes
By the following vote, shareholders approved Amendment No. 2 to the 2019 Incentive Plan: 137,896,8879,337,276106,546 --18,995,441 Majority: yes

Source: INSMED INC., Form 8-K, filed with the SEC on 2025-05-16 — read the filing on EDGAR.

How asset managers voted at the INSMED INC. 2024-2025 meeting

Each item below shows how the 429 asset managers that disclosed a INSMED INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of INSMED INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. AN ADVISORY VOTE ON THE 2024 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-05-15.

Combines 11 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 142,263,777AGAINST: 4,990,969

INSMED INC.’s own tally for this item (“By the following vote, shareholders approved, on an advisory, non-binding basis, the compensation of our named executive officers, as disclosed in the Proxy Statement:”): 142,263,777 for, 4,990,969 against, per its Form 8-K filed 2025-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 181,900,074 outstanding shares: 78% for, 3% against (81% of the company cast a for/against vote).

The 424 asset managers below cast 98% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.

FOR 98%
FOR: 97.6%AGAINST: 2.3%ABSTAIN: 0.0%NOT VOTED: 0.0%
Largest asset managers voting on “AN ADVISORY VOTE ON THE 2024 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.” at INSMED INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price24,884,7510 00For
Vanguard19,107,3820 00For
Capital Group14,304,0860 00For
Fidelity10,117,8472,055,954 00For
BlackRock9,378,5380 00For
JPMorgan9,325,8840 00For
State Street6,992,0590 00For
Artisan3,964,7410 00For
GEODE CAPITAL MANAGEMENT, LLC3,661,8810 00For
ADAGE CAPITAL PARTNERS GP, L.L.C.3,371,9440 00For
Charles Schwab3,193,3120 00For
RTW INVESTMENTS, LP3,014,5580 00For
AllianceBernstein2,973,4500 00For
Columbia Threadneedle2,622,0720 00For
MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST2,086,3380 00For
Invesco2,056,8390 00For
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC1,904,6950 00For
Clearbridge Investments, LLC1,880,5260 00For
PICTET ASSET MANAGEMENT SA1,716,5370 00For
FRANKLIN ADVISERS INC1,548,2440 00For
Loomis Sayles1,516,4820 00For
Janus Henderson1,466,1640 00For
SUVRETTA CAPITAL MANAGEMENT, LLC1,460,1990 00For
American Century1,443,8900 00For
Delaware/Macquarie1,420,0270 00For

Showing the 25 largest of 424 asset managers. See all 424 in the interactive database.

2. RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2025-05-15.

Combines 4 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 160,950,440AGAINST: 5,335,836

INSMED INC.’s own tally for this item (“By the following vote, shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025:”): 160,950,440 for, 5,335,836 against, per its Form 8-K filed 2025-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 181,900,074 outstanding shares: 88% for, 3% against (91% of the company cast a for/against vote).

The 129 asset managers below cast 99.5% of the shares they voted on this item FOR (83,163,163 for, 366,287 against).

FOR 99.5%
FOR: 83,163,163 (99.5%)AGAINST: 366,287 (0.4%)ABSTAIN: 32,118 (0.0%)
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ” at INSMED INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,435,1441,119 00For
T. Rowe Price10,622,2270 00For
Capital Group7,109,6200 00For
Fidelity6,573,3950 00For
BlackRock4,539,6450 00For
JPMorgan3,746,3630 00For
Columbia Threadneedle2,622,0720 00For
State Street1,793,22469 00For
Charles Schwab1,579,3670 00For
Delaware/Macquarie1,420,0270 00For
Lord Abbett1,210,4600 00For
Principal1,136,9330 00For
TIAA1,136,6880 00For
Artisan1,109,9240 00For
MUTUAL FUND SERIES TRUST1,101,3710 00For
JANUS INVESTMENT FUND988,2390 00For
Invesco925,7260 00For
Legg Mason923,3140 00For
Jackson National921,3920 00For
AllianceBernstein779,9810 00For
Bridge Builder Trust750,6790 00For
FRANKLIN STRATEGIC SERIES734,7430 00For
American Century705,8250 00For
Equitable681,5000 00For
WILLIAM BLAIR FUNDS494,1210 00For

Showing the 25 largest of 129 asset managers. See all 129 in the interactive database.

3. Election of two Class I directors, Leo Lee and William H. Lewis, to serve until the 2028 Annual Meeting of Shareholders: Leo Lee

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-15.

Combines 6 wordings of this item as funds reported it.

87% Majority: yes · of votes cast

FOR 87%13%
FOR: 128,784,508WITHHELD: 18,556,201

INSMED INC.’s own tally for this item (“Elect Director: Leo Lee”): 128,784,508 for, 18,556,201 withheld, per its Form 8-K filed 2025-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 181,900,074 outstanding shares: 71% for, 10% withheld (81% of the company cast a for/withheld vote).

The 127 asset managers below cast 100% of the shares they voted on this item FOR (70,467,779 for, 0 against).

FOR 84%ABSTAIN 16%
FOR: 70,467,779 (84.4%)ABSTAIN: 13,072,406 (15.6%)
Largest asset managers voting on “Election of two Class I directors, Leo Lee and William H. Lewis, to serve until the 2028 Annual Meeting of Sha” at INSMED INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,436,2630 00For
T. Rowe Price00 10,622,2270Abstain
Capital Group7,109,6200 00For
Fidelity6,573,3950 00For
BlackRock4,539,6450 00For
JPMorgan3,746,3630 00For
Columbia Threadneedle2,622,0720 00For
State Street1,793,2930 00For
Charles Schwab1,579,3670 00For
Delaware/Macquarie1,420,0270 00For
Lord Abbett1,210,4600 00For
Principal823,1100 313,8230For
TIAA1,136,6880 00For
Artisan1,109,9240 00For
MUTUAL FUND SERIES TRUST1,101,3710 00For
JANUS INVESTMENT FUND988,2390 00For
Invesco925,7260 00For
Legg Mason923,3140 00For
Jackson National875,7300 45,6620For
AllianceBernstein00 779,9810Abstain
Bridge Builder Trust750,6790 00For
FRANKLIN STRATEGIC SERIES734,7430 00For
American Century705,8250 00For
Equitable298,8830 382,6170Abstain
WILLIAM BLAIR FUNDS494,1210 00For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

4. Election of two Class I directors, Leo Lee and William H. Lewis, to serve until the 2028 Annual Meeting of Shareholders: William H. Lewis

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2025-05-15.

Combines 6 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 140,744,212WITHHELD: 6,596,497

INSMED INC.’s own tally for this item (“Elect Director: William H. Lewis”): 140,744,212 for, 6,596,497 withheld, per its Form 8-K filed 2025-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 181,900,074 outstanding shares: 77% for, 4% withheld (81% of the company cast a for/withheld vote).

The 127 asset managers below cast 100% of the shares they voted on this item FOR (82,948,819 for, 0 against).

FOR 99.2%
FOR: 82,948,819 (99.3%)ABSTAIN: 591,366 (0.7%)
Largest asset managers voting on “Election of two Class I directors, Leo Lee and William H. Lewis, to serve until the 2028 Annual Meeting of Sha” at INSMED INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,436,2630 00For
T. Rowe Price10,622,2270 00For
Capital Group7,109,6200 00For
Fidelity6,573,3950 00For
BlackRock4,539,6450 00For
JPMorgan3,746,3630 00For
Columbia Threadneedle2,622,0720 00For
State Street1,793,2240 690For
Charles Schwab1,579,3670 00For
Delaware/Macquarie1,420,0270 00For
Lord Abbett1,210,4600 00For
Principal986,6820 150,2510For
TIAA1,136,6880 00For
Artisan1,109,9240 00For
MUTUAL FUND SERIES TRUST1,101,3710 00For
JANUS INVESTMENT FUND988,2390 00For
Invesco925,7260 00For
Legg Mason923,3140 00For
Jackson National921,3920 00For
AllianceBernstein779,9810 00For
Bridge Builder Trust661,8150 88,8640For
FRANKLIN STRATEGIC SERIES734,7430 00For
American Century705,8250 00For
Equitable681,5000 00For
WILLIAM BLAIR FUNDS494,1210 00For

Showing the 25 largest of 127 asset managers. See all 127 in the interactive database.

5. APPROVAL OF AMENDMENT NO. 2 TO THE INSMED INCORPORATED AMENDED AND RESTATED 2019 INCENTIVE PLAN.

COMPENSATIONMajority of the votes cast: yes

Meeting held 2025-05-15.

Combines 3 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 137,896,887AGAINST: 9,337,276

INSMED INC.’s own tally for this item (“By the following vote, shareholders approved Amendment No. 2 to the 2019 Incentive Plan:”): 137,896,887 for, 9,337,276 against, per its Form 8-K filed 2025-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 181,900,074 outstanding shares: 76% for, 5% against (81% of the company cast a for/against vote).

The 126 asset managers below cast 97% of the shares they voted on this item FOR (81,659,021 for, 2,177,014 against).

FOR 97%
FOR: 81,659,021 (97.4%)AGAINST: 2,177,014 (2.6%)ABSTAIN: 32,118 (0.0%)
Largest asset managers voting on “APPROVAL OF AMENDMENT NO. 2 TO THE INSMED INCORPORATED AMENDED AND RESTATED 2019 INCENTIVE PLAN.” at INSMED INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard18,436,2630 00For
T. Rowe Price10,622,2270 00For
Capital Group7,109,6200 00For
Fidelity6,559,93413,461 00For
BlackRock4,539,6450 00For
JPMorgan3,746,3630 00For
Columbia Threadneedle2,622,0720 00For
State Street1,793,22469 00For
Charles Schwab1,579,3670 00For
Delaware/Macquarie1,420,0270 00For
Lord Abbett1,210,4600 00For
Principal1,136,9330 00For
TIAA1,136,6880 00For
Artisan1,109,9240 00For
MUTUAL FUND SERIES TRUST1,101,3710 00For
JANUS INVESTMENT FUND988,2390 00For
Invesco925,7260 00For
Legg Mason923,3140 00For
Jackson National838,11883,274 00For
AllianceBernstein779,9810 00For
Bridge Builder Trust661,81588,864 00For
FRANKLIN STRATEGIC SERIES734,7430 00For
American Century0705,825 00Against
Equitable681,5000 00For
WILLIAM BLAIR FUNDS494,1210 00For

Showing the 25 largest of 126 asset managers. See all 126 in the interactive database.

6. Amend Omnibus Stock Plan

COMPENSATIONMajority of the votes cast: yes

Meeting held 2025-05-15.

94% Majority: yes · of votes cast

FOR 94%
FOR: 137,896,887AGAINST: 9,337,276

INSMED INC.’s own tally for this item (“By the following vote, shareholders approved Amendment No. 2 to the 2019 Incentive Plan:”): 137,896,887 for, 9,337,276 against, per its Form 8-K filed 2025-05-16 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 181,900,074 outstanding shares: 76% for, 5% against (81% of the company cast a for/against vote).

The 6 asset managers below cast 99.4% of the shares they voted on this item FOR (169,499 for, 1,019 against).

FOR 99.4%
FOR: 169,499 (99.4%)AGAINST: 1,019 (0.6%)
Largest asset managers voting on “Amend Omnibus Stock Plan” at INSMED INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
GuideStone113,4030 00For
Erste Asset Management GmbH47,6000 00For
VALUED ADVISERS TRUST5,0750 00For
RWC Asset Management LLP3,4200 00For
HC CAPITAL TRUST01,019 00Against
Brighthouse10 00For

7. An advisory vote on the 2023 compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-05-13 (outside the 2024-2025 season's 1 July to 30 June window; reported in this season's filings).

Combines 2 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 120,643,045AGAINST: 8,076,144

INSMED INC.’s own tally for this item (“By the following vote, shareholders approved, on an advisory, non-binding basis, the compensation of our named executive officers, as disclosed in the Proxy Statement:”): 120,643,045 for, 8,076,144 against, per its Form 8-K filed 2024-05-13 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 181,900,074 outstanding shares: 66% for, 4% against (71% of the company cast a for/against vote).

The 2 asset managers below cast 0% of the shares they voted on this item FOR (0 for, 580 against).

AGAINST 100%
AGAINST: 580 (100.0%)
Largest asset managers voting on “An advisory vote on the 2023 compensation of our named executive officers.” at INSMED INC., 2024-2025
Asset managerForAgainst AbstainWithheldVote
COLDSTREAM CAPITAL MANAGEMENT INC0580 00Against
Echo45 Advisors LLC00 00--

Largest INSMED INC. shareholders voting in 2024-2025

Ranked by the number of INSMED INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 181,900,074 shares outstanding at the time of that meeting.

Top INSMED INC. shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1T. Rowe Price 13.68%
2Vanguard 10.50%
3Capital Group 7.86%
4Fidelity 6.69%
5BlackRock 5.16%
6JPMorgan 5.13%
7State Street 3.84%
8Artisan 2.18%
9GEODE CAPITAL MANAGEMENT, LLC 2.01%
10ADAGE CAPITAL PARTNERS GP, L.L.C. 1.85%

Reported INSMED INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

INSMED INC. beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
Vanguard Group 10.04% 13F
Darwin Global Management, Ltd. 9.24% 13G
BlackRock 8.82% 13F
T. Rowe Price 7.10% 13F
JPMorgan Chase 3.49% 13F
State Street 3.16% 13F
FMR (Fidelity) 1.87% 13F
Franklin Templeton 1.18% 13F
Invesco 0.98% 13F

Percentages above are of 181,900,074 shares outstanding, as reported by INSMED INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from INSMED INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At INSMED INC.'s shareholder meeting held 2025-05-15, in the 2024-2025 proxy season, 429 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,119 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — AN ADVISORY VOTE ON THE 2024 COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — FOR was 97% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: INSMED INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-16.

INSMED INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.